NACA2
Basic information
Region (hg38): 17:61590420-61591219
Previous symbols: [ "NACAL" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- Inborn genetic diseases (11 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the NACA2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 11 | 11 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region ? | 0 | |||||
non coding ? | 0 | |||||
Total | 0 | 0 | 11 | 0 | 0 |
Variants in NACA2
This is a list of pathogenic ClinVar variants found in the NACA2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
17-61590568-C-A | not specified | Uncertain significance (Nov 08, 2022) | ||
17-61590585-A-T | not specified | Uncertain significance (Jul 27, 2021) | ||
17-61590606-C-T | not specified | Uncertain significance (Mar 07, 2023) | ||
17-61590618-G-A | not specified | Uncertain significance (Feb 14, 2023) | ||
17-61590624-G-A | not specified | Uncertain significance (Apr 07, 2023) | ||
17-61590651-T-G | not specified | Uncertain significance (Jan 24, 2024) | ||
17-61590722-A-C | not specified | Uncertain significance (Feb 13, 2024) | ||
17-61590751-T-C | not specified | Uncertain significance (Apr 05, 2023) | ||
17-61590796-G-T | not specified | Uncertain significance (Jan 30, 2024) | ||
17-61590895-T-C | not specified | Uncertain significance (Mar 02, 2023) | ||
17-61590900-A-G | not specified | Uncertain significance (Sep 06, 2022) | ||
17-61591009-C-T | not specified | Uncertain significance (Feb 16, 2023) | ||
17-61591029-G-T | not specified | Uncertain significance (May 18, 2022) | ||
17-61591144-C-T | not specified | Uncertain significance (May 10, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
NACA2 | protein_coding | protein_coding | ENST00000521764 | 1 | 770 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0324 | 0.625 | 0 | 0 | 0 | 0 | 0.00 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.00242 | 112 | 112 | 0.999 | 0.00000643 | 1382 |
Missense in Polyphen | 28 | 24.027 | 1.1654 | 347 | ||
Synonymous | -1.57 | 61 | 47.3 | 1.29 | 0.00000322 | 442 |
Loss of Function | 0.270 | 2 | 2.46 | 0.814 | 1.07e-7 | 29 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00 | 0.00 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Prevents inappropriate targeting of non-secretory polypeptides to the endoplasmic reticulum (ER). Binds to nascent polypeptide chains as they emerge from the ribosome and blocks their interaction with the signal recognition particle (SRP), which normally targets nascent secretory peptides to the ER. Also reduces the inherent affinity of ribosomes for protein translocation sites in the ER membrane (M sites) (By similarity). {ECO:0000250}.;
Intolerance Scores
- loftool
- 0.730
- rvis_EVS
- 0.95
- rvis_percentile_EVS
- 90.01
Haploinsufficiency Scores
- pHI
- 0.712
- hipred
- N
- hipred_score
- 0.112
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- essential_gene_gene_trap
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.283
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | High | Medium | High |
Primary Immunodeficiency | High | High | High |
Cancer | High | High | High |
Gene ontology
- Biological process
- protein transport
- Cellular component
- nucleus;nascent polypeptide-associated complex
- Molecular function